Active Folic Acid Tablets provide Folic Acid in its natural folate form to support greater absorption. With 400µg of Folic Acid, it is recommended one month prior to conception and for the first 12 weeks to increase maternal folate status. Low maternal folate status is a risk factor in the development of neural tube defects (NTD) in the developing foetus.
Active Folic Acid Tablets contain the patented Quatrefolic® as a source of reduced folate, the nutritionally active form of folate required for optimum absorption.